Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 64 matching records.
64 results — page 1 of 3
- Level BRandomized Controlled TrialEurope PMC
Safety and Efficacy of Micronized Acellular Dermal Matrix Injection for Correction of Moderate to Severe Nasolabial Folds: A Double-Blind, Multicenter, Randomized Controlled, Non-inferior Clinical Trial
Randomized Controlled Trial with a reported sample of 86 on Skin Aging, Facial Rejuvenation, published in Aesthetic Plast Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 86
Aesthetic Plast Surg - Level BClinical TrialPubMed
Clinical efficacy and safety of allogeneic adipose-derived stem cells ELIXCYTE in chronic kidney disease: a phase I/II study.
Clinical Trial on Chronic Kidney Disease, published in Stem Cells Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cells Transl Med - Level DNarrative ReviewPubMed
A Review of the Therapeutic Efficacy and Safety of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Models of Subacute and Chronic Myocardial Infarction.
Narrative Review on Cardiovascular Disease, published in J Cardiovasc Dev Dis (2026) — summary generated from the PubMed abstract.
- 2026
J Cardiovasc Dev Dis - Level BClinical TrialPubMed
Efficacy and safety of autologous adipose-derived stem cells combined with platelet-rich plasma for periodontal regeneration: a multicenter, randomized, open-label, parallel-group comparative trial.
Clinical Trial with a reported sample of 21, published in Regen Ther (2026) — summary generated from the PubMed abstract.
- 2026
- n = 21
Regen Ther1 citations - Level AMeta-analysisPubMed
Efficacy and safety of autologous cell-based therapies for atrophic acne scar treatment: an updated systematic review and meta-analysis with in-depth methodological and clinical insights.
Meta-analysis with a reported sample of 500 on Chronic Wound, Scar, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 500
Front Cell Dev Biol - Level ASystematic ReviewPubMed
A systematic review of clinical evidence on the efficacy and safety of conditioned media, platelet-rich fibrin, stromal vascular fraction, extracellular vesicles, and stem cells in androgenetic alopecia.
Systematic Review with a reported sample of 724 on Hair Loss, Hair Regeneration, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
- n = 724
Stem Cell Res Ther - Level CProspective StudyEurope PMC
Efficacy and Safety of a Defined Two-Dose Protocol of Autologous Platelet-Rich Plasma (PRP) Injection for Refractory Chronic Non-Healing Wounds: A Prospective Clinical Study
Prospective Study with a reported sample of 18 on Chronic Wound, published in Int Wound J (2026) — summary generated from the PubMed abstract.
- 2026
- n = 18
Int Wound J - Level BClinical TrialPubMed
Preclinical safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell medicinal product for rotator cuff repair: a two-phase experimental study.
Clinical Trial with a reported sample of 24 on Tendon Injury, Rotator Cuff, published in J Shoulder Elbow Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 24
J Shoulder Elbow Surg - Level DAnimal StudyPubMed
Preclinical Assessment of Safety and Efficacy of Deferoxamine (DFO)-pretreated Feline Adipose Mesenchymal Stem Cells.
Animal Study on Chronic Inflammation, Immune Modulation, published in In Vivo (2025) — summary generated from the PubMed abstract.
- 2025
In Vivo - Level AMeta-analysisEurope PMC
A meta-analysis and systematic review of the clinical efficacy and safety of platelet-rich plasma combined with hyaluronic acid (PRP + HA) versus PRP monotherapy for knee osteoarthritis (KOA)
Meta-analysis with a reported sample of 1023 on Knee Osteoarthritis, Osteoarthritis, published in J Orthop Surg Res (2025) — summary generated from the PubMed abstract.
- 2025
- n = 1023
J Orthop Surg Res11 citations - Level BClinical TrialPubMed
A Phase 1/2a Clinical Trial to Evaluate the Efficacy and Safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia.
Clinical Trial on Ankle Injury, Peripheral Artery Disease, Chronic Wound, published in Int J Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
Int J Stem Cells - Level BClinical TrialPubMed
Study protocol for a randomized clinical trial evaluating the safety and efficacy of autologous adipose-derived stem cell therapy for ulcers in patients with critical limb ischemia.
Clinical Trial on Peripheral Artery Disease, published in PLoS One (2025) — summary generated from the PubMed abstract.
- 2025
PLoS One - Level ASystematic ReviewPubMed
Clinical Safety and Efficacy of Allogeneic Adipose Stem Cells: A Systematic Review of the Clinical Trials.
Systematic Review with a reported sample of 953 on Osteoarthritis, Chronic Kidney Disease, Scar, Autoimmune Research, published in Int J Mol Sci (2025) — summary generated from the PubMed abstract.
- 2025
- n = 953
Int J Mol Sci2 citations - Level BClinical TrialPubMed
Safety and efficacy of long-shelf-life allogeneic adipose-derived mesenchymal stem cell line-derived platelet-like cells for refractory foot ulcers: A translational preclinical and phase 1/2a study.
Clinical Trial on Chronic Wound, published in Regen Ther (2025) — summary generated from the PubMed abstract.
- 2025
Regen Ther - Level BRandomized Controlled TrialPubMed
Adipose-derived mesenchymal stem cells for the treatment of Amyotrophic Lateral Sclerosis. A phase I/II safety and efficacy clinical trial.
Randomized Controlled Trial with a reported sample of 40 on Neuroinflammation, published in Front Neurol (2025) — summary generated from the PubMed abstract.
- 2025
- n = 40
Front Neurol - Level BClinical TrialEurope PMC
Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cell transplantation in type 2 diabetes: a pilot clinical trial
Clinical Trial on Type 2 Diabetes, Chronic Inflammation, Immune Modulation, published in Am J Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
Am J Stem Cells - Level BClinical TrialEurope PMC
Human umbilical cord mesenchymal stromal cells derivatives in treating diabetic foot ulcers: a phase I/II safety and efficacy trial
Clinical Trial on Type 2 Diabetes, Diabetic Foot, Chronic Wound, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level BClinical TrialPubMed
Efficacy and safety of autologous adipose-derived stem cells in subjects with moderate to severe atopic dermatitis: a multicenter, randomized, single-blind, placebo-controlled, phase 2 trial.
Clinical Trial with a reported sample of 114 on Scar, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
- n = 114
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Regenerative Therapy in Osteoarthritis Using Umbilical Cord-Origin Mesenchymal Stem Cells: A Critical Appraisal of Clinical Safety and Efficacy Through Systematic Review and Meta-Analysis
Meta-analysis with a reported sample of 688 on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in Stem Cells Int (2025) — summary generated from the PubMed abstract.
- 2025
- n = 688
Stem Cells Int1 citations - Level CProspective StudyPubMed
Clinical Evaluation of Safety and Efficacy of a Central Current Good Manufacturing Practices Laboratory Produced Autologous Adipose-Derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoar
Prospective Study on Knee Osteoarthritis, Osteoarthritis, published in Stem Cells Dev (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cells Dev5 citations - Level BClinical TrialPubMed
Safety and efficacy of autologous adipose tissue-derived stem cell transplantation in aging-related low-grade inflammation patients: a single-group, open-label, phase I clinical trial.
Clinical Trial on Type 2 Diabetes, Neuroinflammation, Immune Modulation, published in Trials (2024) — summary generated from the PubMed abstract.
- 2024
Trials - Level BClinical TrialPubMed
Efficacy and safety of autologous or allogeneic mesenchymal stromal cells from adult adipose tissue expanded and combined with tricalcium phosphate biomaterial for the surgical treatment of atrophic nonunion of long bone
Clinical Trial with a reported sample of 14, published in J Transl Med (2024) — summary generated from the PubMed abstract.
- 2024
- n = 14
J Transl Med10 citations - Level BClinical TrialPubMed
The investigation and comparison of the efficacy and safety of stromal vascular fraction (SVF), platelet rich plasma (PRP), and 1064-nm Q-switched Nd:YAG laser in reducing nanofat treated infraorbital dark circles and wr
Clinical Trial with a reported sample of 15 on Skin Aging, published in Skin Res Technol (2024) — summary generated from the PubMed abstract.
- 2024
- n = 15
Skin Res Technol5 citations - Level ASystematic ReviewPubMed
Safety and Efficacy of Bone-Marrow Aspirate Concentrate in Hip Osteoarthritis: A Systematic Review of Current Clinical Evidence.
Systematic Review on Osteoarthritis, Hip Osteoarthritis, published in Indian J Orthop (2024) — summary generated from the PubMed abstract.
- 2024
Indian J Orthop2 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406